4.6 Article

Pretransplant IgG Subclasses of Donor-Specific Human Leukocyte Antigen Antibodies and Development of Antibody-Mediated Rejection

期刊

TRANSPLANTATION
卷 92, 期 1, 页码 41-47

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e31821cdf0d

关键词

HLA antibodies; IgG subclasses; Complement activation; Antibody-mediated rejection; Renal transplantation

资金

  1. Swiss Kidney Foundation
  2. Swiss National Foundation [32473B_125482/1]
  3. Swiss National Science Foundation (SNF) [32473B_125482] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Background. The subclass of IgG antibodies contributes to their capability to activate complement. It is currently unknown whether the pretransplant IgG subclass composition allows distinguishing harmful from presumably irrelevant donor-specific human leukocyte antigen (HLA) antibodies (HLA-DSA) detected by single-antigen flow beads (SAFB). Methods. Seventy-four patients transplanted in the presence of HLA-DSA were investigated. HLA-DSA characteristics were not different between patients experiencing antibody-mediated rejection (AMR) (n = 40) and patients who did not (n = 34) experience AMR. Sera were reanalyzed using SAFB with IgG subclass-specific reporter antibodies. Results. The 74 patients had in total 141 HLA-DSA. IgG(1) was the predominant subclass (78%), followed by IgG(2) (49%), IgG(3) (36%), and IgG(4) (20%). When grouped according to the complement-activating capability, only 4 of 74 patients (5%) had exclusively weak/no complement-activating HLA-DSA (i.e., IgG(2) and IgG(4)), 21 of 74 patients (28%) had isolated strong complement-activating HLA-DSA (i.e., IgG(1) and IgG(3)), and 46 of 74 patients (62%) had a mixture of both. There was no difference between the strong complement-activating and the mixture group regarding incidence of AMR (57% vs. 54%; P=0.81), phenotypes of AMR (P=0.70), and death-censored allograft survival at 5 years (78% vs. 78%; P=0.74). Interestingly, patients with exclusively weak/no complement-activating HLA-DSA (n=4) had a numerically lower incidence of AMR (25%) and no allograft loss has occurred yet. Conclusion. In 90% of patients, pretransplant HLA-DSA are composed of isolated strong or a mixture of strong and weak/no complement-activating IgG subclasses. Because outcomes in these two groups were similar, pretransplant IgG subclass analysis is likely not providing substantial value beyond the standard IgG SAFB assay for pretransplant risk stratification.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据